glp-1 gip lilly Retatrutide just posted the biggest weight-loss numbers ever recorded for a drug — 28.3% (≈70 lb) average in Phase 3, with 45% of people hitting 30%+ loss, territory once reserved for bariatric Lilly's next act in diabetes

For A 25-35 -treated mice, liraglutide dose-dependently prevented against A 25-35 -induced impairment of spatial learning and memory, prevented depression of hippocampal L-LTP, and upregulated intracellular cAMP level (177)

- Aim for blood levels of 100150 nmol/L for optimal function

These modifications extend the half-life of the hormone to 2.4 h [18]

Morieri ML, Frison V, Rigato M, et al

You are trading FDA approval for a lower price

Proponents suggest this delivery method may bypass first-pass hepatic metabolismthe process by which orally administered drugs are partially metabolised by the liver before reaching systemic circulationpotentially improving bioavailability and reducing gastrointestinal side effects commonly associated with oral berberine